Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1966 May;10(5):465-79.

Chemical and serological studies with an iodine-containing synthetic immunological determinant 4-hydroxy-3-iodo-5-nitrophenylacetic acid (NIP) and related compounds

Chemical and serological studies with an iodine-containing synthetic immunological determinant 4-hydroxy-3-iodo-5-nitrophenylacetic acid (NIP) and related compounds

A Brownstone et al. Immunology. 1966 May.

Abstract

The synthesis and properties of 4-hydroxy-3-iodo-5-nitrophenylacetic acid (NIP) and several related compounds are described. Conjugates of NIP with proteins are prepared from the azide, synthesized from commercial 4-hydroxy-phenylacetic acid. Sera from rabbits and mice immunized with NIP—ovalbumin or NIP—chicken serum globulin bind N131IP-containing compounds, as judged from precipitation of radioactivity by salting-out of immunoglobulins. Homogeneous binding is obtained with N131IP—polylysine, N131IP—ε-amino-n-caproic acid (N131IP—aminocap), and other structurally related haptens; non-homogeneous binding is obtained with N131IP—bovine serum albumin. Binding to salt-precipitated immunoglobulin of N131IP—aminocap, the hapten of choice for this purpose, provides an assay for antibody measurable at concentrations down to at least M-9 serum binding capacity (∼0.1 μg antibody/ml). Structurally related compounds and NIP—protein conjugates competitively inhibit binding of N131IP—aminocap. The inhibitions indicate that the iodine contained in NIP, but not the carrier protein, contributes significantly to the binding site.

PubMed Disclaimer

References

    1. Biochem J. 1955 Mar;59(3):405-10 - PubMed
    1. Proc R Soc Lond B Biol Sci. 1964 Dec 15;161:275-92 - PubMed
    1. Biochem J. 1956 Aug;63(4):601-5 - PubMed
    1. J Immunol. 1950 Jun;64(6):487-98 - PubMed
    1. Immunology. 1964 Sep;7:595-602 - PubMed

LinkOut - more resources